| Bart William Mcdonald, MPT | |
|
1800 Flandro Dr, 190, Pocatello, ID 83202-4940 | |
| (208) 233-2248 | |
| (208) 233-0219 |
| Full Name | Bart William Mcdonald |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 24 Years |
| Location | 1800 Flandro Dr, Pocatello, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043332901 | NPI | - | NPPES |
| 5744703 | Other | ID | FIRST HEALTH |
| PT1555 | Other | ID | TRICARE |
| 807400900 | Medicaid | ID | |
| P00320548 | Other | ID | BLUE SHIELD MEDICARE ADV |
| TD646 | Other | ID | BCID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT-1555 (Idaho) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mcdonald Rehab, Pc | 2163505603 | 13 |
News Archive
Sugary drinks are the single biggest contributor to the obesity epidemic in the United States, and according to the Centers for Disease Control, two-thirds of adults and one-third of the children in the U.S. are overweight or obese. Registered dietician Leah Holbrook, Coordinator of the Long Island Center for Pediatric Obesity Prevention in the Department of Family Medicine at Stony Brook School of Medicine, says that these sobering statistics and the fact that beverages account for nearly half of the added sugars in our diet are a wakeup call for Americans to reduce their sugary drink intake.
Impulse Accelerated Technologies today announced that its CoDeveloper C-to-FPGA compiler has been used to develop and deploy a DNA biotechnology genome search algorithm on a new, modular FPGA acceleration platform created by Pico Computing, of Seattle, Washington. The Xilinx FPGA-accelerated bioinformatics algorithm, written in C, performs sequence analysis and pair-match scoring of DNA runs with lengths of 25 base pairs.
The Scottish Medicines Consortium has today announced that Xofigo has been accepted for use within NHS Scotland for the treatment of adult patients with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastases.
Scancell Holdings Plc,, the developer of therapeutic cancer vaccines, is pleased to announce it has signed a worldwide non-exclusive licensing agreement with the National Institutes of Health ('NIH'), a division of the U.S. Department of Health and Human Services, for use of the melanoma antigens TRP-2 and gp100, key components of Scancell's lead ImmunoBody® vaccine for melanoma, SCIB1.
› Verified 9 days ago
| Provider Name | Mcdonald Rehab, Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1497948509 PECOS PAC ID: 2163505603 Enrollment ID: O20080207000254 |
News Archive
Sugary drinks are the single biggest contributor to the obesity epidemic in the United States, and according to the Centers for Disease Control, two-thirds of adults and one-third of the children in the U.S. are overweight or obese. Registered dietician Leah Holbrook, Coordinator of the Long Island Center for Pediatric Obesity Prevention in the Department of Family Medicine at Stony Brook School of Medicine, says that these sobering statistics and the fact that beverages account for nearly half of the added sugars in our diet are a wakeup call for Americans to reduce their sugary drink intake.
Impulse Accelerated Technologies today announced that its CoDeveloper C-to-FPGA compiler has been used to develop and deploy a DNA biotechnology genome search algorithm on a new, modular FPGA acceleration platform created by Pico Computing, of Seattle, Washington. The Xilinx FPGA-accelerated bioinformatics algorithm, written in C, performs sequence analysis and pair-match scoring of DNA runs with lengths of 25 base pairs.
The Scottish Medicines Consortium has today announced that Xofigo has been accepted for use within NHS Scotland for the treatment of adult patients with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastases.
Scancell Holdings Plc,, the developer of therapeutic cancer vaccines, is pleased to announce it has signed a worldwide non-exclusive licensing agreement with the National Institutes of Health ('NIH'), a division of the U.S. Department of Health and Human Services, for use of the melanoma antigens TRP-2 and gp100, key components of Scancell's lead ImmunoBody® vaccine for melanoma, SCIB1.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bart William Mcdonald, MPT 1800 Flandro Dr, 190, Pocatello, ID 83202-4940 Ph: (208) 233-2248 | Bart William Mcdonald, MPT 1800 Flandro Dr, 190, Pocatello, ID 83202-4940 Ph: (208) 233-2248 |
News Archive
Sugary drinks are the single biggest contributor to the obesity epidemic in the United States, and according to the Centers for Disease Control, two-thirds of adults and one-third of the children in the U.S. are overweight or obese. Registered dietician Leah Holbrook, Coordinator of the Long Island Center for Pediatric Obesity Prevention in the Department of Family Medicine at Stony Brook School of Medicine, says that these sobering statistics and the fact that beverages account for nearly half of the added sugars in our diet are a wakeup call for Americans to reduce their sugary drink intake.
Impulse Accelerated Technologies today announced that its CoDeveloper C-to-FPGA compiler has been used to develop and deploy a DNA biotechnology genome search algorithm on a new, modular FPGA acceleration platform created by Pico Computing, of Seattle, Washington. The Xilinx FPGA-accelerated bioinformatics algorithm, written in C, performs sequence analysis and pair-match scoring of DNA runs with lengths of 25 base pairs.
The Scottish Medicines Consortium has today announced that Xofigo has been accepted for use within NHS Scotland for the treatment of adult patients with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastases.
Scancell Holdings Plc,, the developer of therapeutic cancer vaccines, is pleased to announce it has signed a worldwide non-exclusive licensing agreement with the National Institutes of Health ('NIH'), a division of the U.S. Department of Health and Human Services, for use of the melanoma antigens TRP-2 and gp100, key components of Scancell's lead ImmunoBody® vaccine for melanoma, SCIB1.
› Verified 9 days ago
Dr. Jared Denor Lundquist, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2450 Skylar Pl, Pocatello, ID 83201 Phone: 435-339-9058 | |
Mr. Trent Jackman, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Garrison Bldg 63, Room 202, Stop 8045, Pocatello, ID 83209 Phone: 208-282-3065 | |
Laura M Sprague, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 285 Vista Dr, Suite A, Pocatello, ID 83201 Phone: 208-478-1488 Fax: 208-478-1498 | |
Mr. Joshua Strait, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1800 Flandro Dr Ste 190, Pocatello, ID 83202 Phone: 208-233-2248 Fax: 208-233-0219 | |
Kaitlin Bailey Livesay Vail, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 921 S 8th Ave Stop 8045, Pocatello, ID 83201 Phone: 208-282-4095 | |
Streamline Sports Physical Therapy Pc Physical Therapist Medicare: Medicare Enrolled Practice Location: 335 E Lewis St Ste 10, Pocatello, ID 83201 Phone: 208-269-2360 Fax: 208-550-3256 |